Skip to content

ReLine 3804022Recalls & reported problems

Nuvasive, Inc. · RELINE-C Screw, 4.0x22mm · Class 2 · Implant

All models of ReLine (129)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00195377017246), received between Aug 2, 2022 and Aug 2, 2022 — classified as 1 malfunction.

The most frequently reported specific device problem is “Fracture” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Fracture1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionAug 2, 2022Fracture; Fracture

    ON (B)(6) 2022 A POSTERIOR CERVICAL FUSION PROCEDURE WAS PERFORMED AT C2/T1. ON (B)(6) 2022 IT WAS DISCOVERED VIA RADIOGRAPHS THAT THE T1 SCREW SHAFT BROKEN RIGHT AT THE BASE OF THE TULIP ON BOTH SCREWS. NO REVISION SURGERY REQUIRED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15154024 ↗

Other Posterior cervical screw system devices

All Posterior cervical screw system devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page